CRISPR Therapeutics (CRSP) PT Raised to $51 at Citi
Tweet
Share
E-mailGet Alerts CRSP Hot Sheet
Price: $56.82 --0%
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Join SI Premium – FREE
Citi raised its price target on CRISPR Therapeutics (NASDAQ: CRSP) to $51.00 (from $20.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on CRISPR Therapeutics (CRSP)
- CRISPR Therapeutics (CRSP) Reiterated at Market Outperform by Citizens on CTX310 Data
- Hanwa Co Ltd (8078:JP) PT Raised to JPY2,300 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
